BKA-78741-27068
3 vaccinations
5 coded responses
19 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 481 / MI
- Registered
- 2021-05-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-11
Registered in v-safe
-
2021-05-11
Dose 1 — Pfizer-BioNTech
-
2021-05-11
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-13
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-25
-
2021-06-01
Survey response — day 21, dose 1MedDRA: Hypersensitivity, Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Allergies or a coldMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-08
-
2021-06-12
Dose 2 — Pfizer-BioNTech
-
2021-06-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
- 2021-06-21
-
2021-06-26
Survey response — day 14, dose 2MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: GoodFree text: Extra heavy menstrual, starting 4 days early (very uncommon for me)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-17
-
2021-09-11
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
-
2021-12-11
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Dose 3 — Pfizer-BioNTech
-
2022-05-11
Survey response — 3 months, dose 3MedDRA: Delivery — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Pregnancy and birthMedDRA releases: 2024-11 · check-in free text available
- 2022-08-10
- 2023-02-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-11 | Pfizer-BioNTech | |
| 2 | 2021-06-12 | Pfizer-BioNTech | |
| 3 | 2022-02-09 | Pfizer-BioNTech | No |
Free text
Release 8 — day 21, dose 1
Symptoms: Allergies or a cold
Release 9 — day 14, dose 2
Symptoms: Extra heavy menstrual, starting 4 days early (very uncommon for me)
Release 9 — 3 months, dose 2
Symptoms: Pregnant
Release 10 — 6 months, dose 2
Symptoms: Pregnancy
Release 11 — 3 months, dose 3
Symptoms: Pregnancy and birth
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release